About Cypress Our Products Our Research Investor Information Newsroom Contact Home

Corporate Governance Investor FAQs Investor Relations      Stock Information      News      Fundamentals      Analyst Coverage      Earnings Estimates      Dividends and Splits      SEC Filings      Request Information

Summary Fundamentals Price & Volume Recent Price ($) 4.96 Trade Date 03/09/10 52 Week High ($) 9.95 52 Week Low ($) 4.72 YTD Price Percent Change (%) -14.04 Volume (3 Month Average) (Mil) 6.57 Volume (10 Day Average) (Mil) .22 Beta .73 Share Related Market Cap (Total, All Common Classes) (Mil) 189.95 Shares Outstanding (Total, All Classes) (Mil) 38.30 Shares Outstanding, Average (FY) (Mil) 37.73 Dividends Ex-Dividend Date -- Yield (%) -- Income Statement (Mil) Total Revenue 17.16 Total Operating Expense 40.13 Net Income Before Taxes -18.23 Net Income -18.23 Fiscal Year Ending - 12/31/08 Valuation P/E (FY) -- Price to Revenue (FY) 11.07 Price to Book (FY) 1.18 Price to Cash Flow (FY) -- Financial Strength Current Ratio (FY) 18.44 Quick Ratio (FY) 18.44 Total Debt to Equity (FY) (%) -- Profitability Gross Margin (FY) (%) 98.44 Net Profit Margin (FY) (%) -106.21 Management Effectiveness Return on Equity (FY) (%) -11.12 Return on Investment (FY) (%) -10.57 Return on Assets (FY) (%) -10.20 Growth 5 Year Annual Dividend Growth Rate (%) -- 5 Year Annual Revenue Growth Rate (%) --

© 2005-2009 Cypress Bioscience, Inc.

Privacy      Legal Disclaimer